User Tools

Site Tools


documentation:oncology:meeting_notes_2019_mar-12

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revision
Previous revision
documentation:oncology:meeting_notes_2019_mar-12 [2019/03/13 12:04] – mgurleydocumentation:oncology:meeting_notes_2019_mar-12 [2019/03/13 13:38] (current) – mgurley
Line 1: Line 1:
 **Participants** **Participants**
  
-Christian Reich, Rimma Belankaya, Dmytry Dymshyts, Andrew Williams, Robert Miller+Christian Reich, Rimma Belankaya, Dmytry Dymshyts, Andrew Williams, Robert Miller, Michael Gurley
  
 **Topics** **Topics**
-  * 1 +  * Reviewed Dmytry's latest progress on the NAACCR ingestion script. 
-  * 2 +    * Discussed the possibility of moving NAACCR schemas into a new structure to keep the CONCEPT.concept_code clean (not contain anything NOT in NAACCR source data).  But we decided for version 1 we would include NAACCR schemas in the vocabulary, and include NAACCR schema IDs in site-dependent NAACCR items and NAACCR Item Codes.  This means that ETL developers will have to know to use Rimma's ETL code to map NAACCR data into OMOP. 
-  * 3+    * Agreed that mapping NAACCR schemas to ICD site/histology combinations is a must have for version 1 of NAACCR ingestion.  Rimma's ETL SQL will not work without it. 
 +    * Discussed whether NAACCR site-dependent variables should be duplicated across schemas.  Dmytry's first version of NAACCR ingestion is duplicating them.  We agreed that they should not.  Dmytry said he can dedupe them. 
 +    * Resolved "Curate NAACCR Items/Item Codes and OMOP domains":  [[https://github.com/OHDSI/OncologyWG/issues/26]] 
 +    * Resolved "How should we handle long CONCEPT.concept_name entries that exceed 255 characters coming from NAACCR?": [[https://github.com/OHDSI/OncologyWG/issues/28]] 
 +    * Discussed: How should we handle 'Numeric' NAACCR items that define numeric ranges?:https://github.com/OHDSI/OncologyWG/issues/26 
 +    * Resolved "How should we handle NAACCR provenance concepts?": [[https://github.com/OHDSI/OncologyWG/issues/32]] 
 +    * Discussed 'How should we handle versions of staging variables?  For both TNM and AJCC variables?': [[https://github.com/OHDSI/OncologyWG/issues/31]] 
 +    * Resolved "Should we record dates as a separate measurement record.(e.g. Date regional lymph node dissection NAACCR #682)?":https://github.com/OHDSI/OncologyWG/issues/33 
 +    * Resolved "How do we handle different versions of NAACCR?": [[https://github.com/OHDSI/OncologyWG/issues/34]]  
 +     
  
-**Decisions and next steps** 
-  - Submit Diagnosis and Treatment Proposal to the CDM Workgroup 
-  - [[https://docs.google.com/spreadsheets/d/14Gmkypv15scPma-FmyDsxN3CDiRokAj7KaZk_-94xj0/edit?usp=sharing|Detailed Vocabulary Tasks]] 
-  - Collect community use cases here: [[http://forums.ohdsi.org/t/oncology-data-use-cases/4382|oncology-data-use-cases]] 
documentation/oncology/meeting_notes_2019_mar-12.1552478663.txt.gz · Last modified: by mgurley

Donate Powered by PHP Valid HTML5 Valid CSS Driven by DokuWiki